[Evaluation of the effectiveness of diucifon in rheumatoid arthritis and systemic scleroderma].
D000328:Adult; D000893:Anti-Inflammatory Agents; D000936:Antigen-Antibody Complex / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology; D013450:Sulfones / Q000627:therapeutic use*; D014498:Uracil / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000936:Antigen-Antibody Complex; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D013450:Sulfones; C023367:diucifon; D014498:Uracil
Otsenka effektivnosti diutsifona pri revmatoidnom artrite i sistemnoĭ sklerodermii.